home / lobbying / lobbying_activities

lobbying_activities: 823336

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id filing_uuid filing_type registrant_name registrant_id client_name filing_year filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
823336 6de8b44b-ddbb-4a30-9890-26249ed232f2 Q3 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 1466 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 2009 third_quarter MED S.1213, the Patient-Centered Outcomes Research Act of 2009. AACC wrote legislators expressing support for the measure, which would increase federal funding for comparative effectiveness reseach. S. 1679, the Affordable Health Choices Act, Title II, Improving the Quality and Efficiency of Health Care, Subtitle B, Section 219, Center for Health Outcomes Research and Evaluation, Section 937, Center for Health Outcomes Research and Evaluation. AACC wrote to the Senate Health Education Labor and Pensions Committee and contacted Senate staff to express support for retaining the Agency for Healthcare Research and Quality as the leading federal agency responsible for comparative effectiveness research. S. 1679, the Affordable Health Choices Act, Title II, Improving the Quality and Efficiency of Health Care, Subtitle B, Section 219, Center for Health Outcomes Research and Evaluation, Section 937, Center for Health Outcomes Research and Evaluation. AACC joined with other health care organizations in sending a coalition letter to Senate legislators in support of retaining AHRQ as the leading federal agency responsible for comparative effectiveness research. H.R. 3200, America's Affordable Health Choices Act, Division A, Title IV Quality, Section A Comparative Effectiveness Research Section 1401. AACC joined with other health care organizations in sending a coalition letter to House legislators in support of retaining AHRQ as the leading federal agency responsible for comparative effectiveness research. HOUSE OF REPRESENTATIVES,SENATE     0 0 2009-10-07T12:00:48-04:00
Powered by Datasette · Queries took 101.383ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API